Back
Ligand Pharmaceuticals Vs. Pieris Pharmaceuticals Industry Stock Comparison
Buy
56
LGND
Ligand Pharmaceuticals
Last Price:
115.58
Seasonality Move:
10.42%
Sell
34
PIRS
Pieris Pharmaceuticals
Last Price:
16.22
Seasonality Move:
11.68%
Buy
56
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $115.45. The Score for LGND is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy, Sell or Hold?
- The current Pieris Pharmaceuticals [PIRS] share price is $15.95. The Score for PIRS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- PIRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $115.45
The current trend is moderately bullish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.
PIRS Stock Price Chart
What is Pieris Pharmaceuticals's stock price today?
-
The Pieris Pharmaceuticals share price today is $15.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.22 | Buy |
Relative Strength Index (14 RSI): | 52.97 | Buy |
Chaikin Money Flow: | -109873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.5 - 118.96) | Buy |
Bollinger Bands (100): | (93.99 - 111.55) | Buy |
PIRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 39.38 | Sell |
Chaikin Money Flow: | -79315 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.3 - 17.04) | Sell |
Bollinger Bands (100): | (11.57 - 18.63) | Buy |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 120.12 | Sell |
20-day SMA: | 113.75 | Buy |
50-day SMA: | 106.91 | Buy |
200-day SMA: | 90.04 | Buy |
8-day EMA: | 118.66 | Sell |
20-day EMA: | 114.59 | Buy |
50-day EMA: | 108.78 | Buy |
200-day EMA: | 93.47 | Buy |
PIRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.39 | Sell |
20-day SMA: | 16.72 | Sell |
50-day SMA: | 16.66 | Sell |
200-day SMA: | 13.77 | Buy |
8-day EMA: | 16.32 | Sell |
20-day EMA: | 16.55 | Sell |
50-day EMA: | 16.38 | Sell |
200-day EMA: | 17.51 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.38 per share.
Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Ligand Pharmaceuticals Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pieris Pharmaceuticals Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |